Skip to main content

ORIGINAL RESEARCH article

Front. Oncol.

Sec. Radiation Oncology

Volume 15 - 2025 | doi: 10.3389/fonc.2025.1534740

This article is part of the Research Topic Recent Advances in Radiation Oncology for the Management of Thoracic Malignancies View all 4 articles

Artificial Intelligence in Automatic Image Segmentation System for Exploring Recurrence Patterns in Small Cell Carcinoma of the Lung

Provisionally accepted
Jie Shen Jie Shen 1,2,3*Jing Shen Jing Shen 1,2,3Shaobin Wang Shaobin Wang 4Hui Guan Hui Guan 1,2,3Mingyi Di Mingyi Di 5Zhikai Liu Zhikai Liu 1,2,5Qi Chen Qi Chen 6Mei Li Mei Li 1,3Ke Hu Ke Hu 1,2Fuquan ZHANG Fuquan ZHANG 1,3
  • 1 Chinese Academy of Medical Sciences and Peking Union Medical College, Dongcheng, China
  • 2 Peking Union Medical College Hospital (CAMS), Beijing, Beijing Municipality, China
  • 3 Department of Radiation Oncology, Peking Union Medical College Hospital, Department of Medical Oncology, Peking Union Medical College Hospital (CAMS), Beijing, Beijing, China
  • 4 Department of Biomedical Engineering,School of Medicine, School of Medicine, Tsinghua University, Beijing, Beijing Municipality, China
  • 5 Peking university first hospital, Beijing, China
  • 6 MedMind Technology Co., Ltd. Beijing, China, Beijing, China

The final, formatted version of the article will be published soon.

    The integration of artificial intelligence (AI) in automatic image segmentation systems enhances clinical target volume (CTV) evaluation for small cell lung cancer (SCLC). This study analyzed data from 180 SCLC patients (2010–2021) treated with curative radiotherapy, utilizing AI-driven segmentation and recursive feature elimination to model recurrence. Tumor size (≥5cm) independently impacted local control (HR=1.635, p=0.028), with 3-year recurrence rates of 61.1% vs. 86.7% (p=0.004). Recurrence predominantly occurred in regions 10R, 10L, 4R, and 7 (67.65% of cases). A random forest model incorporating 110 clinical variables achieved 77% accuracy in predicting recurrence. AI-based CTV delineation identified initial tumor regions (GTV/GTVnd) as critical recurrence zones, offering a clinically viable tool for optimizing radiotherapy targeting and patient outcomes.

    Keywords: Small Cell Lung Cancer, Clinical target volume (CTV), artificial intelligence, Local recurrence, Prediction model

    Received: 26 Nov 2024; Accepted: 04 Apr 2025.

    Copyright: © 2025 Shen, Shen, Wang, Guan, Di, Liu, Chen, Li, Hu and ZHANG. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Jie Shen, Chinese Academy of Medical Sciences and Peking Union Medical College, Dongcheng, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    95% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more